Axcynsis Therapeutics
@axcynsis.com
About Us Axcynsis Therapeutics is a platform-based biotechnology company focusing on the development of Antibody-X Conjugate (AXC) therapies to revolutionise cancer treatments. Leveraging on proprietary technologies, we are developing a robust pipeline of AXC candidates with the potential to address unmet medical needs for new treatment options. Read More
Axcynsis Therapeutics's Company Logos
Axcynsis Therapeutics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#10589E
Tory Blue
16, 88, 158
210, 82, 34
90, 44, 0, 38
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#004A59
Sherpa Blue
0, 74, 89
190, 100, 17
100, 17, 0, 65
About Axcynsis Therapeutics
Axcynsis Therapeutics is a cutting-edge biotechnology company dedicated to transforming cancer treatment through their Antibody-X Conjugate (AXC) therapies. With a strong focus on innovation, they are leveraging their proprietary technologies to develop a diverse pipeline of AXC candidates that have the potential to address unmet medical needs in the field of cancer treatment.
At Axcynsis Therapeutics, they work tirelessly to stay at the forefront of antibody biology, conjugation, and linker-drug technologies. By harnessing these advanced technologies, they aim to deliver revolutionary therapies that can effectively target and treat cancer cells while minimizing side effects.
Based in Singapore and with an office in China, Axcynsis Therapeutics is positioned to make a global impact. Their dedicated team of experts is committed to pushing the boundaries of science and creating new treatment options for patients in need.
Discover more about their groundbreaking technology and join the fight against cancer with Axcynsis Therapeutics, where innovative solutions meet compassionate care.
Company type
Privately Held
Year founded
2022
Company size
11-50 employees
